risperidone has been researched along with Abnormalities, Drug-Induced in 6 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether in utero exposure to the atypical antipsychotic risperidone is associated with poor pregnancy and fetal/neonatal outcomes." | 8.84 | Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. ( Coppola, D; Kwarta, RF; Russo, LJ; Schmider, J; Varughese, R, 2007) |
| "To determine whether in utero exposure to the atypical antipsychotic risperidone is associated with poor pregnancy and fetal/neonatal outcomes." | 4.84 | Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. ( Coppola, D; Kwarta, RF; Russo, LJ; Schmider, J; Varughese, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ennis, ZN | 1 |
| Damkier, P | 1 |
| Kulkarni, J | 2 |
| Storch, A | 1 |
| Baraniuk, A | 1 |
| Gilbert, H | 1 |
| Gavrilidis, E | 1 |
| Worsley, R | 1 |
| Huybrechts, KF | 1 |
| Hernández-Díaz, S | 1 |
| Patorno, E | 1 |
| Desai, RJ | 1 |
| Mogun, H | 1 |
| Dejene, SZ | 1 |
| Cohen, JM | 1 |
| Panchaud, A | 1 |
| Cohen, L | 1 |
| Bateman, BT | 1 |
| McCauley-Elsom, K | 1 |
| Gurvich, C | 1 |
| Elsom, SJ | 1 |
| Tauqeer, S | 1 |
| Khan, RA | 1 |
| Siddiqui, AA | 1 |
| Coppola, D | 1 |
| Russo, LJ | 1 |
| Kwarta, RF | 1 |
| Varughese, R | 1 |
| Schmider, J | 1 |
4 reviews available for risperidone and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.
Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Hum | 2015 |
Antipsychotic use in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Huma | 2015 |
Antipsychotics in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabete | 2010 |
Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Abortion, Spontaneous; Adult; Antipsychotic Agents; | 2007 |
2 other studies available for risperidone and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Cohort Studies; Female; Heart Defects, Con | 2016 |
Evaluation of teratogenic effects of risperidone following simultaneous administration with antihypertensive and antiemetic drugs.
Topics: Abnormalities, Drug-Induced; alpha-Tocopherol; Animals; Antiemetics; Antihypertensive Agents; Drug E | 2012 |